n-methylnicotinamide has been researched along with chloramphenicol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| CONCHA, E; VEIT, O | 1 |
2 other study(ies) available for n-methylnicotinamide and chloramphenicol
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
[Side effects to the clinical use of chloramphenicol, chlortetracycline and oxytetracycline; variations fecal urobilinogen, prothrombin plasma and urinary excretion of riboflavin and N-1-methyl-nicotinamide].
Topics: Chloramphenicol; Chlortetracycline; Feces; Humans; Niacin; Niacinamide; Nicotinic Acids; Oxytetracycline; Prothrombin; Riboflavin; Urobilinogen | 1956 |